Results 101 to 110 of about 1,913 (212)

Use of intravitreal fluocinolone acetonide implant in inflammatory macular oedema

Eye
Abstract Background/objectives To assess the effectiveness and safety of 0.19-mg fluocinolone acetonide implant (FAc-implant) in inflammatory macular oedema (MO). Subjects/methods This observational, retrospective ...
Chloé Gullon, Sandra Elbany, Nicolas Romain-Scelle, Carole Burillon, Corinne Dot, Thibaud Mathis, Yasmine Serrar, Mariam Ghazaryan, François Devin, Laurent Kodjikian   +9 more
openaire   +1 more source

Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN®)

International Medical Case Reports Journal, 2020
Bernardete Pessoa,1,2 João Melo-Beirão,1,2 Angelina Meireles,1,2 Pedro Menéres1,2 1Ophtalmology Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal; 2Unit for Multidisciplinary Research in Biomedicine ...
Pessoa B, Melo-Beirão J, Meireles A, Menéres P   +3 more
doaj  

Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber

JAMA Ophthalmology, 2020
Li, Angela S., Nguyen, Huy V., Do, Diana V.   +2 more
openaire   +2 more sources

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

BMC Health Services Research, 2019
Background Diabetic macular oedema (DMO) may lead to visual loss and blindness. Several pharmacological treatments are available on the National Health Service (NHS) to United Kingdom patients affected by this condition, including intravitreal vascular ...
Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa   +5 more
doaj   +1 more source

Manejo del edema macular diabético refractario con Ozurdex®. Respuesta clínica [PDF]

, 2017
El edema macular diabético (EMD) constituye una entidad de gran repercusión socio-sanitaria. Tiene una prevalencia elevada y en aumento dentro de los pacientes con retinopatía diabética (RD), suponiendo una importante sobrecarga asistencial en los ...
Fernández Gutiérrez, Javier
core  

A novel intravitreal fluocinolone acetonide implant (Iluvien®) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series

Clinical Ophthalmology, 2015
Vera K Schmit-Eilenberger Augenklinik Städtisches Klinikum, Karlsruhe, Baden-Württemberg, Germany Background: Iluvien® is a novel, nonbiodegradable, sustained-release drug delivery system (0.2 µg/d fluocinolone acetonide [FAc ...
Schmit-Eilenberger VK
doaj  

Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant

Clinical Ophthalmology, 2012
John D Sheppard Jr1, Quan Dong Nguyen2, Dale W Usner3, Timothy L Comstock3, for the Fluocinolone Acetonide Uveitis Study Group1Eastern Virginia Medical School, Norfolk, VA, USA; 2Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, MD,
Sheppard Jr JD, Nguyen QD, Usner DW, Comstock TL; Fluocinolone Acetonide Uveitis Study Group   +3 more
doaj  

Gestione dell'edema maculare diabetico [PDF]

, 2011
Gestione dell'edema maculare diabetico, nuove ...
CAPUTO, SILVESTRO
core  

Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)

International Medical Case Reports Journal, 2019
Jessica D McCluskey, Paul L Kaufman, Kathy Wynne, Gregory LewisDepartment of Ophthalmology, Thomas Eye Group, Atlanta, GA, USAObjective: To assess long-term outcomes for effectiveness, safety, and treatment burden after injection of 0.2 μg/day ...
McCluskey JD, Kaufman PL, Wynne K, Lewis G   +3 more
doaj  

Vitreous Band Formation and the Sustained-Release, Intravitreal Fluocinolone (Retisert) Implant [PDF]

Archives of Ophthalmology, 2007
Anat, Galor, Ron, Margolis, Peter K, Kaiser, Careen Y, Lowder   +3 more
openaire   +2 more sources